Credit Card Icon
Online bill pay
Calendar Icon
Book Now
Filed Paper Icon
patient portal
Doctor Icon
For Physicians
Phone Icon
(763) 416-7600

Keratoplasty Explained: Procedure, Recovery, and Outcomes

Posted by: Northwest Eye in keratoplasty on September 3, 2025

Keratoplasty replaces damaged corneal tissue

Keratoplasty replaces damaged or diseased corneal tissue with healthy donor tissue. Your cornea is the clear front layer of your eye, and it focuses incoming light. A keratoplasty procedure may be considered when disease, injury, scarring, or swelling prevents the cornea from working properly.

The treatment is not one single operation. The damaged corneal layer and the reason for treatment help determine whether you need a full-thickness transplant, a front-layer transplant, or an inner-layer transplant. This guide explains those options, the evaluation, recovery, warning signs, expected outcomes, and reported U.S. costs.

Reported costs vary widely because estimates may cover different services and different follow-up periods. A 2013 U.S. cost estimate put the average one-year cost per patient at approximately $16,500, or $20,138 in 2020 dollars. That estimate included corneal tissue, surgeon and anesthesia services, facility costs, preoperative care, and related services.

This estimate is not a current personal quote.

Knowing the warning signs and keeping follow-up appointments remain important after the initial recovery period.

Corneal damage can have several causes

Corneal damage can result from a severe eye injury, an infection, or a medical condition. A serious injury may keep the cornea from healing correctly. A transplant may improve vision or, in a severe injury, may be the only way to close the wound.

Keratoconus makes the cornea thin and weak. Pressure inside the eye can then make it bulge outward in a cone shape and cause severe vision problems. Pseudophakic bullous keratopathy is swelling and clouding of the cornea after cataract surgery, and it is a common reason for transplantation.

Some infections and medical conditions can damage, thin, or cloud the cornea enough that replacing it may be needed. The same diagnosis can affect different layers, so the condition alone does not determine the transplant type.

In a study of 362 eyes undergoing tectonic keratoplasty, inflammation was the most common listed indication at 18.8%, followed by trauma at 18.2% and infection at 18.2%.

The study reported tectonic failure in 18 of 362 eyes, or 5.0%. Severe lid disease, central anterior lamellar keratoplasty, and peripheral grafts were reported risk factors in that study. These figures describe a specific group treated for serious structural corneal problems, not every person considering a transplant.

Postoperative astigmatism can affect vision after the cited corneal transplant procedure. Approximately 1 in 5 patients may develop it in that report. Possible contributors include the size and position of the corneal opening, graft sizing, corneal thickness, suture placement, and medications.

Infographic stat row showing common indications in a tectonic keratoplasty study: inflammation 18.8%, trauma 18.2%, and infection 18.2%.
Inflammation, trauma, and infection were reported at similar rates in this study.

Vision changes can prompt an eye examination

Blurry, distorted, painful, cloudy, or changing vision can occur when the cornea is damaged or misshapen. These changes do not identify the cause by themselves.
Keratoconus, corneal scarring, infections, and swelling after cataract surgery can affect vision in different ways. Bring a clear description of when the change began, whether it affects one or both eyes, and whether pain or light sensitivity occurs with it.

Healing after a corneal transplant is gradual. Blurry vision, light sensitivity, irritation, and changing vision can occur during recovery, so your care team will interpret these symptoms in context rather than judging the result from one early visit.

A retrospective German study of 2,956 first-time keratoplasty eyes treated for Fuchs endothelial corneal dystrophy reported different recovery times by procedure. In that study, reaching best-corrected visual acuity of at least 6/12 Snellen took 7.8 months after DMEK, 12.4 months after DSAEK, and 37.9 months after PK. Those study results do not predict your personal timeline.

Infographic chart showing median recovery time to best-corrected visual acuity of at least 6/12 Snellen: 7.8 months after DMEK, 12.4 months after DSAEK, and 37.9 months after PK. The chart compares three transplant types.
Recovery was shortest after DMEK and longest after PK in this study.

An eye doctor matches treatment to the cornea

A doctor recommends corneal transplantation only after a careful examination of your eye. The evaluation focuses on the condition and layer of the cornea, the cause of the damage, and how the problem affects your vision.

Before surgery, your ophthalmologist discusses why you need the transplant, how it may help you see better, and what to expect during and after surgery. Useful questions include which corneal layer is damaged, which transplant type is being considered, how long vision may change, and what warning signs require a prompt call.

A retrospective study of 2,956 first-time keratoplasty eyes at a high-volume German transplant center treated for Fuchs endothelial corneal dystrophy found that Fuchs dystrophy was the most frequent indication in that group. A study’s most frequent indication does not establish the cause of your own corneal problem.

The same German study measured outcomes by transplant type, disease, and follow-up period. That distinction matters because results from one condition or surgical method should not be applied automatically to another.

Corneal transplantation is performed in many settings. In 2019, 51,336 corneal transplants were performed in the United States, compared with 32,313 other organ transplants. This number describes national procedure volume, not the likelihood that you need surgery.

Infographic bar chart comparing 51,336 corneal transplants with 32,313 other organ transplants in the United States in 2019. It shows national procedure counts from the cited comparison.
Corneal transplants outnumbered the other organ transplants in this comparison.

The damaged layer helps determine the transplant type

The damaged corneal layer helps determine which transplant is considered. The main options differ in how much tissue is removed, what donor tissue replaces it, and how the graft is held in place.

Transplant type Tissue replaced Practical distinction
Penetrating keratoplasty (PK) The full thickness of the cornea A full-thickness donor graft is sewn into place.
Deep anterior lamellar keratoplasty (DALK) Diseased front layers Your own endothelium, the inner layer, remains in place when it is healthy.
Endothelial keratoplasty The damaged inner layer A thin donor layer replaces the endothelium that helps keep the cornea clear.

Your eye surgeon chooses the transplant type based on the condition of your cornea.

Penetrating keratoplasty, or PK, replaces the full thickness of your cornea with a donor graft that is sewn into place. DALK replaces diseased front layers while keeping your own endothelium, the inner layer, in place.

DALK may be useful for stromal disease when your endothelium is healthy. Examples include keratoconus without hydrops, partial-thickness scars, and stromal dystrophies. The operation may need to change if the deeper layer cannot be preserved, so the final choice depends on what the surgeon finds.

Endothelial keratoplasty replaces the damaged inner corneal layer with healthy donor tissue. Damage to this layer can make the cornea swell and affect vision.

DSAEK tissue may be easier to position because it is thicker. DMEK tissue is thinner and more difficult to transplant, but recovery is quicker because the tissue is thinner. These are general procedural differences; your surgeon matches the method to the corneal condition.

Results differ across studies because the procedures, diseases, and patient groups differ. In one German cohort, 10-year graft survival was 92% for PK, 75% for DMEK, and 73% for DSAEK. In a separate tectonic-keratoplasty study, mean physiological graft survival among anatomically successful central grafts was 96 months; 10-year survival was 66.8% for anterior lamellar grafts and 44.2% for PK.

Long-term immune-rejection rates were 1.7–13% for DALK, 5–11.4% for DSAEK, and 1.7–2.8% for DMEK. In the German study, the cumulative probability of reaching best-corrected visual acuity of at least 6/12 Snellen within 5 years was 93% after DMEK, 83% after DSAEK, and 63% after PK. These figures are not a ranking for individual treatment because the underlying conditions and study groups were not identical.

Surgery is usually outpatient, but preparation matters

Corneal transplant surgery is usually performed as an outpatient procedure. Your surgeon uses local or general anesthesia so you do not feel pain. Eye drops and other medicine may be given before surgery, and a device keeps the eye open while the operation is performed.

The donor tissue is placed according to the damaged layer. A full-thickness graft may be sewn into the cornea. Some endothelial procedures use a small incision, a thin donor disc on the back surface of the cornea, and an air bubble to hold the disc in place while it heals.

Before surgery, your ophthalmologist should explain why the transplant is needed, what to expect, and how it may help your vision. Tell the ophthalmologist about every medicine you take. The surgery date may change if a suitable donor cornea is not ready.

Use this preparation list:

  • Ask which transplant type is planned and which corneal layer it treats.
  • Ask which medicines you should continue or stop. Do not change them without instructions.
  • Arrange for someone to drive you home. You will not be able to drive after corneal-transplant surgery.
  • Ask when your first follow-up visit will occur and which symptoms require a call.

Corneal tissue also has separate preparation and reimbursement steps. Cited Medicare Part B and Medicare Advantage guidance identifies HCPCS code V2785 for processing, preserving, and transporting corneal tissue. The same guidance identifies CPT add-on code 65757 for backbench preparation of a corneal endothelial allograft before transplantation. These codes describe billing categories, not a price for your surgery.

Recovery depends on the transplant type

Partial-thickness transplants often heal faster than full-thickness transplants. After PK, complete vision recovery may take up to 1 year or longer. Your vision may keep changing for a year or more while the graft heals and sutures are managed.

Blurry vision, light sensitivity, irritation, and changing vision can occur during healing. Recovery is not instant, so early vision does not necessarily show the final result. Your follow-up visits allow the ophthalmologist to monitor the graft and respond to changes.

After PKP, your surgeon starts steroid drops to control inflammation and lower rejection risk. Prophylactic antibiotic drops should be used 4 to 6 times a day for at least the first two weeks, according to the prescribed plan. Steroid-drop schedules vary considerably, with no consensus on the dose, duration, and taper, so follow your surgeon’s instructions rather than changing the schedule yourself.

Use eye protection after a corneal transplant. Have an ophthalmologist monitor for potential complications. Follow-up is part of recovery because graft clarity and survival depend on rejection episodes, postoperative complications, and endothelial cell density, an important indicator of graft survival and clarity.

Some conditions may reduce graft success and should be discussed before surgery. They include herpetic keratitis, glaucoma, and inflammation inside the eye. Reported high-risk graft factors also include blood-vessel growth in 2 or more corneal quadrants, trephination over 8.25 mm, herpes simplex keratitis, silicone oil keratopathy, a failed graft, infection, inflammation, and younger age.

In a cited review, endothelial rejection and related endothelial cell loss accounted for 25% of failed grafts after PK. The figure comes from that review and does not represent the risk for every transplant type.

Some postoperative changes have specific next steps. Mild astigmatism may be treated with lenses or glasses. If it remains troublesome, the surgeon may consider suture adjustment or selective suture removal, relaxing incisions, laser treatment, corneal ring segments, or an intraocular-lens procedure. If these measures are ineffective, repeat corneal transplantation may be needed. When interrupted sutures contribute, selective removal may be considered. Continuous sutures are significantly more difficult to adjust. Inflammation and blood-vessel growth should be reduced before further correction is considered.

Diffuse corneal swelling that does not clear after the immediate postoperative period can indicate primary endothelial failure. This can cloud the donor cornea and reduce vision. A smaller graft, increased eye pressure, glaucoma, or previous glaucoma surgery may raise that risk. These findings are reasons for the ophthalmologist to examine the graft rather than signs you should interpret without an exam. Follow-up visits are where these changes are assessed.

Outcomes and risks are not identical

More than 47,000 corneal transplants are performed in the United States each year, and most patients have improved vision and less eye pain after surgery. Individual outcomes depend on the transplant type, the disease being treated, the health of the eye, and the healing process.

Both DALK and PK can significantly improve vision and refraction. DALK and PK can have similar visual results, although PK may produce better visual outcomes in some cases. Reported 10-year graft survival ranges from 74.1% to 97.1% for DALK and from 72% to 96.4% for PK. The range changes with the disease being treated and the proportion of high-risk grafts.

Reported rejection rates differ by transplant type and study. The risk is lower with partial-thickness transplants. Immune rejection remains the leading cause of graft failure in PK. DALK, DSAEK, and DMEK have lower immune-rejection rates than PK in long-term comparisons.

Possible problems after corneal transplantation include infection, bleeding, retinal detachment, glaucoma from increased eye pressure, and astigmatism. Other eye diseases, such as glaucoma, diabetic retinopathy, or macular degeneration, may also limit vision even when the transplant itself is functioning.

Plan for the full cost, not just the surgery

The study measured total costs in its defined population, not the amount every patient pays out of pocket.

Medicare coverage and your out-of-pocket responsibility can depend on the plan, deductible, facility, transplant type, and services included. A cited coverage summary describes Part B coverage for eligible outpatient corneal-transplant costs and possible additional help from Medigap, but your insurer must provide the terms that apply to you.

Before scheduling surgery, request a procedure-specific estimate. Ask which items are included:

  • The surgeon, anesthesia, facility, and donor tissue
  • Preoperative testing and postoperative visits
  • Prescription drops and other medicines
  • Suture management or later procedures, if needed
  • Your deductible, coinsurance, and coverage limits

Corneal tissue processing and transport may appear as separate billing categories. The cited reimbursement guidance identifies HCPCS code V2785 for processing, preserving, and transporting corneal tissue. A current estimate should identify the planned procedure and the services it covers.

Call the eye-care team when warning signs appear

Mild irritation, dust, or allergy redness usually resolves within a day or two without pain, light sensitivity, or vision changes. Contact your eye doctor whenever a transplanted eye becomes red without an obvious, short-lived cause. Have an ophthalmologist monitor for possible complications after a corneal transplant, and use the prescribed drops as directed.

Rejection is not limited to the first weeks after surgery. One clinical report found that rejection occurred about 20 months after keratoplasty on average, but it could occur up to 20 years later. Risk varies by transplant type, so the date of surgery alone cannot rule it out. If new symptoms appear after a stable period, contact the eye-care team rather than assuming they are ordinary irritation or waiting for a routine appointment. Prompt treatment may be able to stop rejection.

Book an eye evaluation to discuss keratoplasty

Bring your questions about the damaged corneal layer, transplant type, recovery timeline, warning signs, prescribed drops, and procedure-specific costs to an eye evaluation. A qualified eye-care professional can decide whether keratoplasty relates to your corneal condition and what evaluation is needed. For care in the Twin Cities area, you can book an eye evaluation at Northwest Eye in Minnetonka.

Ask these questions before choosing a plan

How should I compare a keratoplasty cost estimate?

Compare estimates by checking whether they include donor tissue, surgeon and anesthesia services, facility fees, preoperative testing, follow-up visits, prescription drops, and possible later procedures. Ask your insurer about the deductible, coinsurance, coverage limits, and facility rules. Historical estimates are not personal quotes, so request a current, procedure-specific estimate before scheduling.

What should I ask at a keratoplasty consultation?

Ask which corneal layer is damaged, which transplant type is being considered, and why it fits your condition. Also ask what donor tissue will be used, what visual outcome to expect, how long vision may change, which drops and follow-up visits are expected, what symptoms require an urgent call, and which medicines you should continue or stop. Do not change medicines without instructions.

Can blurry vision be normal after keratoplasty?

Blurry or changing vision can occur during healing, especially because recovery is gradual and varies by transplant type. After a full-thickness transplant, vision may continue changing for a year or longer. Call your care team right away for blurred vision with pain, redness, light sensitivity, new floaters, flashes, or a dark curtain-like shadow.


locations

Serving Our Community

With six locations throughout the Twin Cities metro area, Northwest Eye is among the largest eye care providers in the Midwest. Be Eye Wise and schedule a general eye exam or a specific service consultation today. We have optical  at the following offices:  Golden Valley, Minnetonka, Maple Grove, St. Anthony, and Wayzata, MN.

8501 Golden Valley Rd.,
Suite 100 & 200
Golden Valley, MN 55427
Additional Golden Valley Information
12501 Whitewater Drive, Suite 110
Minnetonka, MN 55343
Additional Minnetonka Clinic (Crosstown) Information
12000 Elm Creek Blvd N., Suite 100
Maple Grove, MN 55369
Additional Maple Grove Information
2601 39th Ave NE., Suite 1
St. Anthony, MN 55421
Additional St. Anthony Information
1903 E. Wayzata Blvd., Suite 110
Wayzata, MN 55391

Additional Wayzata Information
7125 Tamarack Rd, Suite 150,
Woodbury, MN 55125
Additional Woodbury Information
11091 Ulysses St NE., Suite 400
Blaine, MN 55434
Additional Blaine Surgery Center Information
9801 Dupont Ave S., Suite 100
Bloomington, MN 55431
Additional Bloomington Surgery Center Information
12501 Whitewater Drive
Suite 320
Minnetonka, MN 55343
Additional Crosstown Surgery Center Information
10709 Wayzata Blvd., Suites 100 & 120
Minnetonka, MN 55305
Additional Minnetonka Surgery Center Information